DE60216570D1 - Verfahren zum nachweis von alzheimer-krankheit - Google Patents

Verfahren zum nachweis von alzheimer-krankheit

Info

Publication number
DE60216570D1
DE60216570D1 DE60216570T DE60216570T DE60216570D1 DE 60216570 D1 DE60216570 D1 DE 60216570D1 DE 60216570 T DE60216570 T DE 60216570T DE 60216570 T DE60216570 T DE 60216570T DE 60216570 D1 DE60216570 D1 DE 60216570D1
Authority
DE
Germany
Prior art keywords
alzheimer disease
detecting alzheimer
disease
alzheimer
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216570T
Other languages
English (en)
Other versions
DE60216570T2 (de
Inventor
Zsuzsanna Nagy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Application granted granted Critical
Publication of DE60216570D1 publication Critical patent/DE60216570D1/de
Publication of DE60216570T2 publication Critical patent/DE60216570T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/99—Isomerases (5.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60216570T 2001-03-12 2002-03-12 Verfahren zum nachweis von alzheimer-krankheit Expired - Lifetime DE60216570T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0106051.6A GB0106051D0 (en) 2001-03-12 2001-03-12 Diagnostic screens for alzheimer's disease
GB0106051 2001-03-12
PCT/GB2002/001137 WO2002073212A2 (en) 2001-03-12 2002-03-12 Diagnostic screens for alzheimer's disease

Publications (2)

Publication Number Publication Date
DE60216570D1 true DE60216570D1 (de) 2007-01-18
DE60216570T2 DE60216570T2 (de) 2007-04-05

Family

ID=9910482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216570T Expired - Lifetime DE60216570T2 (de) 2001-03-12 2002-03-12 Verfahren zum nachweis von alzheimer-krankheit

Country Status (9)

Country Link
US (1) US20040132113A1 (de)
EP (2) EP1370870B9 (de)
JP (3) JP4430306B2 (de)
AT (1) ATE347698T1 (de)
AU (1) AU2002238766A1 (de)
DE (1) DE60216570T2 (de)
ES (1) ES2272673T3 (de)
GB (1) GB0106051D0 (de)
WO (1) WO2002073212A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
GB0311835D0 (en) * 2003-05-22 2003-06-25 Isis Innovation Susceptibility gene for alzheimer's disease
EP1816460B1 (de) * 2006-02-03 2009-07-22 MTM Laboratories AG Verfahren zur Durchführung eines Denaturierungs-Immunoassays
WO2010112034A2 (en) * 2009-04-02 2010-10-07 Aarhus Universitet Compositions and methods for treatment and diagnosis of synucleinopathies
GB0912394D0 (en) * 2009-07-16 2009-08-26 Univ Birmingham Screening methods
GB201112246D0 (en) * 2011-07-15 2011-08-31 Univ Birmingham Diagnosis of alzheimer's disease
GB201212334D0 (en) 2012-07-11 2012-08-22 Warwick The Therapeutic targets for alzheimers disease
CN103808919B (zh) * 2014-03-16 2015-11-18 国家烟草质量监督检验中心 一种基于溴脱氧尿嘧啶核苷掺入的卷烟烟气增殖毒性评价方法
CN103808917B (zh) * 2014-03-16 2015-11-04 国家烟草质量监督检验中心 一种电子烟烟液细胞增殖毒性评价方法
WO2019113277A1 (en) * 2017-12-08 2019-06-13 NeuroDiagnostics LLC Diagnosing disease via gene expression profile in synchronized cells
KR102478811B1 (ko) 2020-08-21 2022-12-16 재단법인대구경북과학기술원 멀티플렉스 ｐｃｒ 플랫폼 기반의 알츠하이머 질환 진단을 위한 신규한 마커 조성물 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500087A (ja) * 1992-06-24 1997-01-07 コーテックス ファーマシューティカルズ インコーポレイテッド カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法
US5773219A (en) * 1992-10-06 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Process for detecting Alzheimer disease using cultured cells
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
AU2541497A (en) * 1996-04-04 1997-10-29 Institute Of Genomic Research, The Variant presenilin-2 genes
US6342350B1 (en) * 1997-09-05 2002-01-29 The General Hospital Corporation Alpha-2-macroglobulin diagnostic test
WO2000079000A1 (en) * 1999-06-22 2000-12-28 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method for detection of early-onset alzheimer's disease

Also Published As

Publication number Publication date
EP1724588B1 (de) 2017-05-03
JP2008245654A (ja) 2008-10-16
DE60216570T2 (de) 2007-04-05
ATE347698T1 (de) 2006-12-15
EP1370870B9 (de) 2009-12-02
JP2010166922A (ja) 2010-08-05
JP2004531244A (ja) 2004-10-14
EP1724588A3 (de) 2007-09-05
US20040132113A1 (en) 2004-07-08
JP4430306B2 (ja) 2010-03-10
EP1370870B1 (de) 2006-12-06
WO2002073212A2 (en) 2002-09-19
WO2002073212A3 (en) 2003-05-22
AU2002238766A1 (en) 2002-09-24
EP1370870A2 (de) 2003-12-17
ES2272673T3 (es) 2007-05-01
JP4541429B2 (ja) 2010-09-08
EP1724588A2 (de) 2006-11-22
GB0106051D0 (en) 2001-05-02

Similar Documents

Publication Publication Date Title
ATE526041T1 (de) Verfahren zur hemmung okularer vorgänge
DE60115314D1 (de) Verfahren für die Auswertung von Bildern zur Defekterkennung
DE60224383D1 (de) Verfahren zum nachweis in hefe für mittels die proteinfaltung beeinflussen
DE60228160D1 (de) System und Verfahren zum Durchführen von drahtlosen Transaktionen
ATE386942T1 (de) Verfahren zur voraussage, zur diagnose und zur vergleichenden diagnose von alzheimer
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
DE60216570D1 (de) Verfahren zum nachweis von alzheimer-krankheit
DE602004022124D1 (de) Verfahren und Anordung zur Begutachtung der Qualität von maschineller Übersetzung
ATE540319T1 (de) Verfahren für die bestimmung von fk506
HK1079571A1 (en) Methods for direct detection of individual methotrexate metabolites
DE60235211D1 (de) Verfahren zum Vorlöschen von Rauschen eines Bildes.
DE60322848D1 (de) System für kontinuierliche leistungstests
DE60321356D1 (de) Verfahren zur diagnostik von eierstock endometriose
ATA1242002A (de) Verfahren und einrichtung zum optischen testen von halbleiterbauelementen
DE602005026665D1 (de) Angereicherter antikörper zur detektion von mikrobakterieller infektion, verfahren zur anwendung und diagnosetest damit
ATE426172T1 (de) Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE393394T1 (de) Verfahren zum nachweis von proteinen, die miteinander interagieren
ATE306659T1 (de) Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
DE60234465D1 (de) Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE602004030819D1 (de) Angiogenesehemmende moleküle und ihre verwendung bei der behandlung und diagnose von krebs
DE60239364D1 (de) Prozessor zum Umwandeln von Informationssignalen und entsprechendes Verfahren
DE60210584D1 (de) Verfahren, vorrichtung und programm zum erhalt von reifeninformation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition